Atlas Trials

Autoimmune Pulmonary Alveolar Proteinosis

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Autoimmune Pulmonary Alveolar Proteinosis

RecordFirmDate
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (NCT04544293)Savara Inc.2021-05-19
The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis (NCT03531996)Children's Hospital Medical Center, Cincinnati2018-04-19
Safety Extension Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (NCT03482752)Savara Inc.2018-04-16
Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis (NCT03006146)Children's Hospital Medical Center, Cincinnati2017-07-13
Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (NCT02702180)Savara Inc.2016-03-21
Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP) (NCT02243228)Peking Union Medical College Hospital2014-08-01
Inhaled GM-CSF Therapy of Autoimmune PAP (NCT00901511)Fondazione IRCCS Policlinico San Matteo di Pavia2009-07-01
Molgramostim Nebulizer Solution Expanded Access Program Protocol (NCT06546098)Savara Inc.

Track Autoimmune Pulmonary Alveolar Proteinosis automatically

Every clearance here is in the API, with alerts when new ones post.